Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
AbbVie
Josef S Smolen; Aileen L Pangan; Paul Emery; William Rigby; Yoshiya Tanaka; Juan Ignacio Vargas; Ying Zhang; Nemanja Damjanov; Alan Friedman; Ahmed A Othman; Heidi S Camp; Stanley Cohen